MarketCap
Facebook
X
Telegram
AVITA Medical Long-Term Debt | RCEL
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 42.2 M | 39.8 M | 306 K | 918 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.2 M | 306 K | 20.8 M |
Quarterly Long-Term Debt AVITA Medical
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.82 M | 1.98 M | - | 42.2 M | 41.5 M | 42.2 M | 42.5 M | 41 M | 41.3 M | 39.8 M | 1.84 M | 1.05 M | 1.24 M | 306 K | 405 K | 532 K | 726 K | 918 K | 1.11 M | 878 K | 878 K | 1.24 M | 1.78 M | 1.92 M | 1.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.5 M | 306 K | 13 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sintx Technologies
SINT
|
2.84 M | $ 1.74 | 6.75 % | $ 4.83 M |  USA |
 |
Smith & Nephew plc
SNN
|
149 M | $ 27.87 | 0.16 % | $ 24.2 B |  Britain |
 |
Stryker Corporation
SYK
|
14.9 B | $ 276.43 | 0.68 % | $ 106 B | USA |
 |
Tandem Diabetes Care
TNDM
|
310 M | $ 19.88 | 0.4 % | $ 1.35 B | USA |
 |
Sensus Healthcare
SRTS
|
209 K | $ 3.16 | 0.94 % | $ 51.6 M | USA |
 |
Viemed Healthcare
VMD
|
11.3 M | $ 8.79 | 0.78 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
366 M | $ 18.49 | 0.03 % | $ 765 M | USA |
 |
NuVasive
NUVA
|
872 K | - | - | $ 2.07 B | USA |
 |
Vivos Therapeutics
VVOS
|
469 K | $ 0.18 | 6.76 % | $ 1.85 M | USA |
 |
TELA Bio
TELA
|
55.7 M | $ 0.83 | 1.05 % | $ 39 M | USA |
 |
Beyond Air
XAIR
|
1.02 M | $ 3.38 | 0.93 % | $ 28.1 B | USA |
 |
Zimmer Biomet Holdings
ZBH
|
6.93 B | $ 94.22 | 0.69 % | $ 18.7 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.13 M | $ 8.23 | 0.71 % | $ 600 M |  Israel |
 |
Axonics Modulation Technologies
AXNX
|
25.8 M | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
Medigus Ltd.
MDGS
|
607 K | - | 10.28 % | $ 55.5 M | Israel |
 |
Inari Medical
NARI
|
30.4 M | - | - | $ 4.23 B | USA |
 |
Nemaura Medical
NMRD
|
3.09 M | - | -17.8 % | $ 2.74 M | Britain |
 |
Neovasc
NVCN
|
273 K | - | - | $ 111 M |  Canada |
 |
SmileDirectClub
SDC
|
849 M | - | -53.45 % | $ 9.71 M | USA |
 |
Sientra
SIEN
|
55.4 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
75.6 M | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
10.6 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
732 M | - | - | $ 12.3 B | USA |
 |
ThermoGenesis Holdings
THMO
|
131 K | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
16.8 M | - | 3.55 % | $ 7.96 M | USA |
 |
Viveve Medical
VIVE
|
425 K | - | -15.35 % | $ 1.71 M | USA |
 |
ViewRay
VRAY
|
73.3 M | - | 1.54 % | $ 468 M | USA |
 |
Titan Medical
TMDI
|
981 K | - | -26.32 % | $ 19.6 M | Canada |
 |
Natus Medical Incorporated
NTUS
|
6.57 M | - | 1.94 % | $ 1.05 B | USA |
 |
Acutus Medical
AFIB
|
25.6 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Profound Medical Corp.
PROF
|
4.5 M | $ 6.81 | 1.32 % | $ 206 M | Canada |
 |
Tactile Systems Technology
TCMD
|
16 M | $ 21.73 | 0.09 % | $ 497 M | USA |
 |
Abbott Laboratories
ABT
|
9.9 B | $ 105.52 | 0.03 % | $ 184 B | USA |
 |
Aethlon Medical
AEMD
|
337 K | $ 1.81 | 1.09 % | $ 1.22 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 6.19 | 1.09 % | $ 837 M | USA |
 |
Align Technology
ALGN
|
82.5 M | $ 153.49 | 0.03 % | $ 11.1 B | USA |
 |
Apyx Medical Corporation
APYX
|
34.8 M | $ 3.05 | 0.33 % | $ 125 M | USA |
 |
Accuray Incorporated
ARAY
|
146 M | $ 0.26 | 0.37 % | $ 31.9 M | USA |
 |
Alphatec Holdings
ATEC
|
501 M | $ 9.19 | 1.29 % | $ 1.38 B | USA |
 |
AxoGen
AXGN
|
48.4 M | $ 46.69 | 2.51 % | $ 2.15 B | USA |
 |
Butterfly Network
BFLY
|
17.7 M | $ 7.52 | 2.17 % | $ 1.86 B | USA |